Greenwich LifeSciences GLSI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 9.95 | 100.55 | -0.30 | -4,175 | -4 | |
| 2025Q2 | 9.07 | 100.52 | -0.30 | -4,046 | -4 | |
| 2025Q1 | 9.54 | 100.74 | -0.25 | -3,282 | -3 | |
| 2024Q4 | 11.23 | 100.55 | -0.61 | -8,084 | -8 | |
| 2024Q3 | 14.37 | 102.25 | -0.21 | -2,729 | -3 | |
| 2024Q2 | 17.26 | 102.11 | -0.20 | -2,661 | -3 | |
| 2024Q1 | 19.94 | 102.59 | -0.19 | -2,537 | -2 | |
| 2023Q4 | 10.52 | 103.24 | -0.21 | -2,836 | -3 | |
| 2023Q3 | 8.84 | 104.64 | -0.19 | -2,503 | -2 | |
| 2023Q2 | 9.65 | 107.31 | -0.12 | -1,748 | -2 | |
| 2023Q1 | 13.79 | 105.46 | -0.17 | -2,241 | -2 | |
| 2022Q4 | 15.20 | 103.73 | -0.22 | -2,895 | -3 | |
| 2022Q3 | 9.10 | 102.76 | -0.18 | -2,383 | -2 | |
| 2022Q2 | 8.47 | 103.62 | -0.06 | -773 | -1 | |
| 2022Q1 | 19.62 | 101.02 | -0.15 | -1,989 | -2 | |
| 2021Q4 | 24.33 | 100.72 | -0.18 | -2,377 | -2 | |
| 2021Q3 | 39.07 | 100.46 | -0.06 | -867 | -1 | |
| 2021Q2 | 44.94 | 100.53 | -0.06 | -753 | -1 | |
| 2021Q1 | 34.09 | 100.67 | -0.05 | -601 | -1 | |
| 2020Q4 | 36.47 | 100.09 | -0.12 | -1,152 | -1 |